Fellowships-Non Federal
Search Funding
Funding Resources
Funding Newsletter Archive
|
|
|
Greetings!
We hope that you find this publication helpful in your funding search. We also encourage you to visit our intranet funding page, which offers more information on funding resources available to faculty and fellows.
|
DFCI Limited Applications
| Please follow the link below to see announcements of current internal deadlines, how the process works, and contact information.
DFCI Limited Applications
|
|
|
|
|
Internal Funding
Dana-Farber/Harvard Cancer Center (DF/HCC) SPORE in Prostate Cancer
Specialized Program of Research Excellence (SPORE)
Developmental Research Award
DF/HCC SPORE in Prostate Cancer seeks applications for Developmental Research Projects in Prostate Cancer Translational Research. Applicants must be on the faculty at Harvard Medical School or the Harvard School of Public Health at the level of Instructor or higher. The applicant would become a member of the DF/HCC Prostate Cancer Program and the DF/HCC Prostate Cancer SPORE and would be expected to attend SPORE activities (meetings, retreats, research presentations). Women and minority candidates are encouraged to apply.
Amount: $50,000 for 1 year
Deadline: May 29, 2015
Dana-Farber/Harvard Cancer Center (DF/HCC) SPORE in Prostate Cancer
Specialized Program of Research Excellence (SPORE) Career Enhancement Award
DF/HCC SPORE in Prostate Cancer seeks applications for Career Enhancement Awards in Prostate Cancer Translational Research. Eligible applicants are either in their final year of clinical or postdoctoral fellowship, or hold an academic appointment not higher than Assistant Professor at Harvard Medical School or the Harvard School of Public Health. The applicant would become a member of the DF/HCC Prostate Cancer Program and the DF/HCC Prostate Cancer SPORE and would be expected to attend SPORE activities (meetings, retreats, research presentations). Women and minority candidates are encouraged to apply.
Amount: $50,000 for 1 year
Deadline: May 29, 2015
Dana-Farber cancer Institute (DFCI)
2015 Friends of Dana Farber Allocations
For 39 years, the Friends have supported a wide range of activities within the Institute. The Friends endow an oncology fellow every year and allocate significant funds to a variety of projects in research, nursing, and patient care. The Friends have also completed pledges to the Women's Cancers Program, prostate cancer, and head and neck research. Applications are accepted from all departments at DFCI. Applicants may only submit one proposal. Proposals from young investigators and/or new initiatives are particularly encouraged.
Amount: $30,000 for 1 year
Deadline: June 29, 2015
|
|
Federal Funding
| |
Non-Federal Funding-Grants
Elsa U. Pardee Foundation
Grant Applications
The Elsa U. Pardee Foundation funds research to investigators in the United States proposing research directed toward identifying new treatments or cures for cancer. The Foundation particularly encourages grant applications for a 1 year period which will allow establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified. Applications requesting more than 15% overhead are usually not considered.
Amount: No set limit
Deadline: June 1, 2015
The Cure Starts Now (CSN)
Universal Grant Application
CSN is dedicated to educating, aiding and funding the search for a cure for brainstem glioma and other forms of pediatric brain cancer in the hopes of curing all cancers. The Foundation seeks to fund research investigating cures for pediatric brain cancers with a focus on Diffuse Intrinsic Brainstem Glioma (DIPG). CSN's focus is to support translational and clinical research projects in those areas. The DIPG Collaborative is a collective group of over 20 foundations seeking transparency, the elimination of duplication, efficiency and collaboration in research of DIPG. Working through the operations of the founding member CSN, it seeks to pool research funding in a way that not only increases DIPG research but also coordinates the actions of many diverse foundations.
Amount: $100,000 for 1 year
Deadline: June 1, 2015
American Gastroenterological Association (AGA)
AGA Microbiome Junior Investigator Research Award
The overall goal of the AGA research awards program is to enable investigators, especially those in the early stages of their careers, to develop and maintain independent and productive research programs in digestive diseases. The specific objective of this award is to encourage and facilitate innovative research into relationships between the gut microbiome and functioning of the digestive system in health and disease. Preference will be given to applicants who have not previously received an R01 or similar major research awards from NIH or other funding agencies but recipients of such awards are eligible for funding under this mechanism. Recipients of this award must be full members of the AGA. Applicants who are not AGA members at the time of application must apply for and be accepted as members before funding will be released. The applicant must have a sponsor and a preceptor.
Amount: $30,000/ year for 2 years
Deadline: June 5, 2015
American Gastroenterological Association (AGA)
AGA-Boston Scientific Career Development Technology and Innovation Award
This award funds young investigators working toward independent careers in gastroenterology, hepatology, or related areas focused on technology and innovation. This award is intended to support young faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research. Applicants should be in the beginning years of their careers; therefore, established investigators are not appropriate candidates. AGA membership is required at the time of application submission. Applicants are required to have a sponsor and preceptor for the award; however, one individual may serve in the capacity of both positions. At the time of application submission, applicants may not hold or have held an NIH R01, R21, K08, K01, K23, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources. Applicants with an active K12 may apply.
Amount: $75,000/ year for 2 years
Deadline: June 5, 2015
Foundation for Women's Wellness (FWW)
2015 Women's Health Research Awards
FWW Research Awards target early funding for small, short-term studies with promise for improving medical knowledge in cardiovascular disease, leading female cancers, the role of hormones in disease and stage-of-life health issues such as pregnancy and menopause and diseases disproportionately affecting women. FWW favors research proposals that have direct clinical application in preventing and/or treating disease; studies with the promise of yielding results that will attract larger sources of funding for advancing study; and influencing long-term research directions in its field. Non-overlapping financial support and existing or pending financial support necessary to complete research must be in place if FWW monies are being used as partial or supplemental funds. Only one application per applicant will be considered.
Amount: $25,000 for 1 year
Deadline: June 8, 2015
Susan G. Komen
Career Catalyst Research Grants (CCR)
Susan G. Komen is committed to ending breast cancer forever by empowering people, energizing science to find the cures, and ensuring quality care for all people, everywhere. CCR Grants are intended to foster promising breast cancer researchers who are in the early stages of their faculty careers by providing support for up to three years of "protected time" for research career development under the guidance of a Mentor Committee. It is expected that awardees will launch independent research careers and successfully compete for subsequent research project funding in breast cancer following the successful completion of a CCR Grant. Basic/Translational CCR Grants are intended for early faculty members who are proposing research projects that are laboratory- or field-based and do not meet Komen's definition of clinical research. CCR-Clinical Research Grants provide support for hypothesis-driven clinical research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move toward the goal of a world without breast cancer. Applicants may only submit one application to each focus area (Basic/Translational or Clinical) per funding cycle, but may accept only one grant if awarded. Applicants must be able to commit at least 75% of full-time effort to research. Applicants must not simultaneously hold a Komen Postdoctoral Fellowship (PDF) Grant. If a PDF grant is currently held, the PDF grant term must expire before the start of the CCR, if funded. If the Applicant is the recipient of a previous Komen CCR grant, the awarded CCR must end within 3 months of receiving Notification of Intent to Fund for the FY16 cycle or the funding will be withdrawn. Applicants must not currently be a PI on an existing R01 research grant or Komen Initiated Investigator Research (IIR) grant. Applicants must not have held any faculty appointment, including non-tenure and tenure track appointments combined, for more than total of 6 years at the time of full Application submission (November 9, 2015).
Amount: $150,000/ year for 3 years
Deadline: Pre-application; June 17, 2015
|
American Gastroenterological Association (AGA)-Gilead Sciences
AGA-Gilead Sciences Research Scholar Award in Liver Disease
The overall objective of the Research Scholar Award is to enable young investigators, instructors, research associates or equivalents to develop independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for research. This award is intended to support young faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research. Applicants should be in the beginning years of their careers; therefore, established investigators are not appropriate candidates. AGA membership is required at the time of application submission. Applicants are required to have a sponsor and preceptor for this award; however, one individual may serve in the capacity of both positions. At the time of application submission, applicants may not hold or have held an NIH R01, R21, K08, K01, K23, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources. Applicants with an active K12 may apply.
Amount: $90,000/ year for 3 years
Deadline: June 25, 2015
The North American Neuroendocrine Tumor Society (NANETS)
Young Investigator Award
The purpose of the NANETS Young Investigator Award is to encourage investigators at the end of their fellowship or beginning of their faculty appointment to pursue basic and/or translational research focused on neuroendocrine tumors. Applicants must be in the first 5 years of a faculty appointment. Applicants must be a NANETS member.
Amount: $50,000 for 1 year
Deadline: June 29, 2015
Children's Leukemia Research Association, Inc. (CLRA)
Research Grants
CLRA is on the leading edge of research, stimulating and facilitating the opportunity for new avenues of investigation. CLRA funds research grants for doctors who are conducting the most promising research in leukemia, in the hopes of isolating the causes and finding a cure for this dread disease. The objective is to direct the funds into the most promising projects, and where funding would not duplicate other funding sources. Any doctor who is involved in research towards finding the causes and cure for leukemia may apply.
Amount: $30,000 for 1 year
Deadline: June 30, 2015
Alex's Lemonade Stand Foundation (ALSF)
Bio-Therapeutics Impact Award
ALSF Bio-Therapeutics Impact award provides funding to support investigator-initiated clinical trials using biologic therapies, including but not limited to immunotherapy (including cell therapies), gene therapy and small molecules. This grant category was initiated to accelerate the development of clinical trials for promising biologic approaches to treat childhood cancers. This funding opportunity includes support for the following: Clinical trials in which all pre-clinical studies have been completed, an IND has been approved and funding is needed to conduct and complete the clinical trial, and pre-clinical funding available for investigators who need to perform IND enabling studies. Subsequent funding of the trial will be contingent upon first obtaining all necessary regulatory approvals.
Amount: $1.5 million over 3 years. Please see specific eligibility requirements for more detailed funding breakdowns
Deadline: June 30, 2015
Accelerate Brain Cancer Cure (ABC2)
Research Grants
ABC2 provides researchers with the pivotal support they need to make critical breakthroughs. ABC2 funds novel translational research aimed at finding the fastest possible route to a cure for brain cancer. ABC2's projects are quite diverse: from creating targeted therapeutics to improving drug delivery to developing new preclinical screening mouse models to honing diagnostic biomarkers. In the last several years, ABC2's research funding has targeted the following areas: developing and identifying new therapies for glioblastoma multiforme(GBM) tumors, advancing precision medicine for GBM, low grade brain tumors, and pediatric brain tumors.
Amount: No set limit
Deadline: Rolling
Solving Kids' Cancer (SKC)
Therapeutic Development Initiative (TDI)
2015 Funding for High-Impact Pediatric Cancer Research
SKC is committed to significantly improving survivorship of the deadliest childhood cancers. SKC sponsors pilot, proof-of-principle, and Phase I clinical trials that drive a gained understanding of both safety and efficacy of promising therapeutic agents. TDI is SKC's strategic platform for the implementation of our research agenda as well as the vehicle for reviewing and prioritizing submitted research proposals. TDI's goal is to support innovative clinical studies that are high on the risk/reward spectrum while, at the same time, investigating these research questions efficiently and effectively. Priority is given to proposals that introduce therapeutic agents and modalities which are first-in-children and have a strong potential to improve treatment outcomes. TDI supports clinical testing of promising therapies that may significantly and fundamentally improve treatment for children with pediatric cancer. The clinical study must focus on neuroblastoma, pediatric CNS tumors and/or sarcomas.
Amount: Up to $60,000 for 1 year
Deadline: Rolling; Clinical Idea of Intent submitted first
|
Non-Federal Funding-Fellowships
|
Prostate Cancer Foundation (PCF)
2015 Young Investigator Award
PCF champions human capital investment to fast-forward solutions for prostate cancer with the ultimate goal of ending death and suffering from prostate cancer. Applicants may be working in basic, translational, or clinical research and need not be trained specifically in prostate cancer research. Applicants may hold title of Senior Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor, or equivalent. Applicants must be under the direct supervision of a mentor(s). Applicants should have received no more than $200,000 in current direct research funding from all sources including institutional funds. Applicants who have specifically received young investigator research support from NIH, or DoD are still qualified and very much encouraged to apply.
Amount: $75,000/ year for 3 years
Deadline: June 3, 2015
Susan G. Komen
Postdoctoral Fellowship Grants (PDF)
PDF Grants are intended to attract and support promising scientists and clinician/scientists who are embarking on careers dedicated to breast cancer research. PDF-Basic and Translational Research Grants are appropriate for fellows who are proposing research projects that are laboratory- or field- based, and do not meet Komen's definition of clinical research. PDF-Clinical Research Grants provide support for hypothesis-driven clinical research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move toward the goal of a world without breast cancer. Applicants may not currently be, or have formerly been, a fellow on a Komen PDF Grant. Applicants may only submit one application to each focus area (Basic/Translational or Clinical) per funding cycle but may accept only one grant if awarded. Applicants must be able to commit at least 75% of full-time effort to research.
Amount: $60,000/ year for 2-3 years
Deadline: Pre-application; June 17, 2015
Helen Hay Whitney Foundation (HHWF)
Research Fellowships
HHWF supports early postdoctoral research training in all basic biomedical sciences. HHWF accepts applications from applicants who have no more than one year of postdoctoral research experience at the time of the deadline for submitting the application (July 1, 2015). Since the number of available fellowships is limited, the Foundation does not make more than one award per year for training with a given supervisor. It also does not support more than two fellows per laboratory at one time. No more than one application from a laboratory will be reviewed during each annual cycle.
Amount: $160,500 over 3 years
Deadline: July 1, 2015
|
Search for Funding Using SPIN
DFCI subscribes to InfoEd International SPIN ™
SPIN
InfoEd's SPIN (Sponsored Programs Information Network) currently contains information from more than 10,000 different sponsoring agencies, which together fund over 40,000 separate funding opportunities. Options include features such as: Quick Search, Advanced Searching Capabilities, and the Federal Register. Please see the 'Training Videos' on the SPIN site for more information on SPIN and its features.
Please ensure that you have logged into InfoEd in the web browser you are using, otherwise you will not be able to access SPIN. |
|
|
|
